Patient Recruitment AI

Assess feasibility, match patients, and track enrollment pipeline

Patient Recruitment AI

AI-powered patient matching, cohort management, and recruitment funnel analytics

Total Patients

57%

Eligible Rate

43%

Consent Rate

Avg Eligibility

Recruitment Funnel

Patient Pool

850

Screened

340

-60%

Eligible

186

-45%

Consented

142

-24%

Enrolled

-31%

Active

-22%

Completed

-70%

Overall conversion: 3%Screen-to-enroll: 29%

Cohort Management

Status

Country

Min Score0

Patient	Age	Gender	Country	Site	Conditions	Eligibility	Status
W.N.	44	Male	Poland	Centrum Medyczne HCP, Poznan	M05.79 - Seropositive RA, multiple sitesJ45.20 - Mild intermittent asthma	95	active
J.M.	62	Male	🇨🇭Switzerland	CHUV Lausanne	C34.1 - NSCLC, upper lobeJ44.1 - COPD with acute exacerbation+1	94	active
S.A.	33	Female	🇬🇧United Kingdom	Maudsley Hospital, London	F33.2 - MDD, recurrent, severeG43.9 - Migraine, unspecified	93	eligible
H.G.	57	Female	🇬🇧United Kingdom	Guy's Hospital, London	C50.9 - Breast cancer, unspecifiedC77.3 - Lymph node metastasis, axillary	92	eligible
A.S.	55	Female	🇩🇪Germany	Charite Berlin	C34.9 - NSCLC, unspecifiedI10 - Essential hypertension	91	active
N.W.	46	Female	Czech Republic	VFN Praha, Prague	M05.79 - Seropositive RA, multiple sitesM15.0 - Primary generalized osteoarthritis	91	active
F.T.	64	Male	🇩🇪Germany	Universitatsklinikum Heidelberg	E11.65 - Type 2 DM with hyperglycemiaN18.3 - CKD Stage 3+2	90	active
D.L.	39	Female	🇫🇷France	Hopital Sainte-Anne, Paris	F33.2 - MDD, recurrent, severeF41.1 - Generalized anxiety disorder	89	consented
E.V.	59	Female	🇪🇸Spain	Hospital Clinic Barcelona	M05.79 - Seropositive RA, multiple sitesE03.9 - Hypothyroidism+1	88	active
K.O.	58	Female	Netherlands	UMC Utrecht	E11.65 - Type 2 DM with hyperglycemiaN18.3 - CKD Stage 3+1	87	active
B.H.	61	Male	Hungary	Semmelweis University, Budapest	M05.79 - Seropositive RA, multiple sitesI10 - Essential hypertension+1	87	completed
G.F.	68	Male	🇨🇭Switzerland	HUG - Hopitaux Universitaires de Geneve	C34.1 - NSCLC, upper lobeE11.9 - Type 2 DM+1	86	active
H.W.	47	Female	Netherlands	Erasmus MC, Rotterdam	F33.2 - MDD, recurrent, severeF90.0 - ADHD, predominantly inattentive	86	withdrawn
M.K.	48	Female	🇩🇪Germany	LMU Klinikum Munich	C22.0 - Hepatocellular carcinomaB18.1 - Chronic viral hepatitis B+1	85	eligible
S.L.	41	Female	🇪🇸Spain	Hospital Universitario La Paz, Madrid	C50.2 - Breast cancer, upper inner quadrantC78.0 - Lung metastasis	85	pool
M.R.	69	Male	Belgium	UZ Leuven	E11.65 - Type 2 DMN18.3 - CKD Stage 3b+1	84	enrolled
J.K.	50	Male	🇫🇷France	Hopital Paul Brousse, Villejuif	C22.0 - Hepatocellular carcinomaB18.2 - Chronic viral hepatitis C+1	83	consented
R.P.	72	Male	🇫🇷France	Hopital Necker, Paris	E11.22 - Type 2 DM with diabetic CKDN18.4 - CKD Stage 4+1	82	enrolled
O.M.	36	Male	Norway	Oslo University Hospital	F33.1 - MDD, recurrent, moderate	81	pool
L.S.	66	Male	🇨🇭Switzerland	Inselspital, Bern	C22.0 - Hepatocellular carcinomaK74.60 - Cirrhosis, unspecified+1	79	eligible
V.C.	43	Female	🇫🇷France	Centre Leon Berard, Lyon	C50.4 - Breast cancer, upper outer quadrantC77.3 - Lymph node metastasis, axillary+1	78	pool
A.J.	51	Female	Finland	HUS Helsinki University Hospital	F33.2 - MDD, recurrent, severeF40.10 - Social phobia	76	pool
P.G.	63	Male	Romania	Institutul Oncologic, Bucharest	E11.65 - Type 2 DMN18.3 - CKD Stage 3a+1	74	pool
P.D.	71	Male	🇫🇷France	Institut Gustave Roussy	C34.3 - NSCLC, lower lobeE78.5 - Dyslipidemia+1	72	screened
R.D.	58	Female	🇩🇪Germany	Universitatsklinikum Essen	C50.9 - Breast cancer, unspecifiedC78.7 - Liver metastasis+1	68	pool
E.P.	74	Male	Poland	Szpital Kliniczny, Warsaw	E11.22 - Type 2 DM with diabetic CKDN18.4 - CKD Stage 4+1	41	screened
L.B.	67	Male	🇫🇷France	Hopital Beaujon, Clichy	C22.0 - Hepatocellular carcinomaK70.3 - Alcoholic cirrhosis+1	38	screened
I.Z.	54	Female	🇮🇹Italy	Istituto Nazionale Tumori, Milano	C34.9 - NSCLC, unspecifiedC79.31 - Brain metastasis	35	screened
T.B.	45	Male	🇩🇪Germany	Charite Berlin, Dept. Psychiatry	F33.1 - MDD, recurrent, moderateF10.20 - Alcohol use disorder, moderate	25	screened
C.R.	52	Female	🇫🇷France	Hopital Cochin, Paris	M05.79 - Seropositive RA, multiple sitesK50.9 - Crohn's disease, unspecified	22	screened

Showing 30 of 30 patients

Patient Recruitment AI

Patient Recruitment AI

Recruitment Funnel

Cohort Management

FGFR+ NSCLC European Pool

HCC Post-IO Progression Registry

MTX-IR RA Central European Cohort

DKD UACR>200 Manual Selection

AI Patient Matching